Research

Mixed

The Adaptive Ketogenic–Mediterranean Protocol (AKMP) utilizes dynamic, biomarker-guided adjustments to metabolic adaptation (adaptive thermogenesis) to sustain weight loss, whereas GLP-1 agonists fail to counteract the resulting decline in energy expenditure.

If you are using a ketogenic or low-carb approach and hit a weight loss plateau, do not just restrict calories further. Monitor your metabolic markers (like ketones and blood sugar). If you stall, the protocol suggests dynamically adjusting your macronutrients—specifically increasing protein and adjusting fats—to leverage the metabolic advantage of ketosis and counteract the natural drop in energy expenditure that occurs during weight loss.

LimitedSupportsLOW confidence
Unlike GLP-1 receptor agonists—which primarily suppress appetite, require ongoing pharmacotherapy, and do not directly mitigate the decline in energy expenditure—the AKMP couples a Mediterranean foundation for adherence with a ketogenic metabolic advantage and a biomarker-guided adjustment system explicitly designed to counter metabolic adaptation, aiming to improve the durability of weight loss and patient self-management.
Cayetano García-Gorrita et al. · Nutrients · 2025

Why this rating

The AKMP is presented as a theoretical construct; evidence for its specific dynamic protocol is not yet available in clinical trials.

Source

Beyond GLP-1 Agonists: An Adaptive Ketogenic–Mediterranean Protocol to Counter Metabolic Adaptation in Obesity Management

Cayetano García-Gorrita et al. · Nutrients · 2025

DOI 10.3390/nu17162699

narrative_reviewCited 3×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →